The Club Méditerranée Foundation supports the SMILES association in Belgium, to improve the medical care provided to children with HIV.
About the Smiles association
The Smiles association, which was founded in 1999, restores the smile on the faces of children affected by HIV, who are being treated at the Saint-Pierre University Hospital of Brussels. The goal of this association is to provide these young patients with medical care at the cutting edge of scientific progress, as well as the multidisciplinary support that will help them to continue their treatment at home, and help their families to cope more effectively, given the restrictions imposed by their condition. Smiles' work is focused on the following three priority objectives:
- Improving the well-being of children on a daily basis by allowing sick teenagers to participate in European conferences where they can share their experience with other young people suffering from the same disease. Medical holidays and snacks at the hospital are also organized.
- Increasing the size of the medical, psychological, nursing and social team in order to ensure children affected by HIV and their families are given the right treatment, while also providing the medical team with the resources they need to organise support activities.
- Supporting the clinical research activities, which are essential in order to provide more effective treatment methods that can be directly applied to the patients.
With the Club Méditerranée Foundation
The Club Méditerranée Foundation provides financial support to the SMILES Association in Belgium and participates in charitable initiatives by getting its employees involved when visiting the young people of the Saint-Pierre hospital in Brussels and organising fundraising events.
Use of the collected funds
The objective of the 'Web App Workshop' is to join forces with a group of teenage human immunodeficiency virus (HIV) carriers and the team of the paediatrics ward of the Saint Pierre University Hospital to create a mobile application to assist children and teenagers in managing the disease on a daily basis by themselves. The stakes are high because if this treatment is poorly monitored, the virus can mutate and develop a resistance to the molecules of the antiretroviral therapy. During adolescence, the treatment is particularly hard to accept because of what other people may think, the patient's acceptance of authority and the learning associated with a self treatment.